Biblio

Author Title [ Type

] Year

Filters: Author is Cohen, Sandra [Clear All Filters]

Journal Article

Claveau J-S, LeBlanc R, Ahmad I, Delisle J-S, Cohen S, Kiss T, Bambace NM, Bernard L, Lachance S, Roy DClaude, et al. Bortezomib maintenance after allogeneic transplantation in newly diagnosed myeloma patients results in decreased incidence and severity of chronic GVHD. Transplant Cell Ther. 2022.

Tang F, Xu D, Wang S, Wong CKhuan, Martinez-Fundichely A, Lee CJ, Cohen S, Park J, Hill CE, Eng K, et al. Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Science. 2022;376(6596):eabe1505.

Lemieux C, Ahmad I, Bambace NM, Bernard L, Cohen S, Delisle J-S, Fleury I, Kiss T, Mollica L, Roy D-C, et al. Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Lymphoma Patients. Biol Blood Marrow Transplant. 2019.

Politikos I, Davis E, Nhaissi M, Wagner JE, Brunstein CG, Cohen S, Shpall EJ, Milano F, Scaradavou A, Barker JN. Guidelines for Cord Blood Unit Selection. Biol Blood Marrow Transplant. 2020.

Lachance S, Bourguignon A, Boisjoly J-A, Bouchard P, Ahmad I, Bambace N, Bernard L, Cohen S, Delisle J-S, Fleury I, et al. Impact of Implementing a Bendamustine-based Conditioning Regimen on outcomes of Autologous Stem Cell Transplant in Lymphoma while Novel Cellular Therapies Emerge. Transplant Cell Ther. 2022.

Cohen S, Bambace N, Ahmad I, Roy J, Tang X, Zhang M-J, Burns LJ, Barabé F, Bernard L, Delisle J-S, et al. Improved Outcomes of UM171-Expanded Cord Blood Transplantation Compared with Other Graft Sources: Real-World Evidence. Blood Adv. 2023.

Garcia-Rosa M, Abraham A, Bertaina A, Bhoopalan SVelan, Bonfim C, Cohen S, Dezern A, Louis C, Oved J, Pavel-Dinu M, et al. International society for cell & gene therapy stem cell engineering committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant. Cytotherapy. 2023.

Claveau J-S, Cohen S, Ahmad I, Delisle J-S, Kiss T, Lachance S, Sauvageau G, Busque L, Brito R-M, Bambace N, et al. Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors. Eur J Haematol. 2020.

Fares I, Rivest-Khan L, Cohen S, Sauvageau G. Small molecule regulation of normal and leukemic stem cells. Curr Opin Hematol. 2015;22(4):309-316.

Klein OR, Bonfim C, Abraham A, Ruggeri A, Purtill D, Cohen S, Wynn R, Russell A, Sharma A, Ciccocioppo R, et al. Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering. Cytotherapy. 2023.

Dumont-Lagacé M, Li Q, Tanguay M, Chagraoui J, Kientega T, Cardin GB, Brasey A, Trofimov A, Carli C, Ahmad I, et al. UM171-expanded cord blood transplants support robust T cell reconstitution with low rates of severe infections. Biol Blood Marrow Transplant. 2020.